Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonists
- 12 September 1994
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 262 (3) , 233-245
- https://doi.org/10.1016/0014-2999(94)90737-4
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonistsNature, 1993
- The cholecystokinin hypothesis of panic and anxiety disorders: a reviewJournal of Psychopharmacology, 1992
- Penetration of adenosine antagonists into mouse brain as determined by ex vivo bindingBiochemical Pharmacology, 1992
- Cholecystokinin-Tetrapeptide Induces Panic Attacks in Patients with Panic DisorderThe Canadian Journal of Psychiatry, 1990
- The role of CCK, caerulein, and CCK antagonists in nociceptionPain, 1989
- Electrophysiological studies with new CCK analogs: Correlation with binding affinity on B-type receptorsPeptides, 1989
- Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260Journal of Medicinal Chemistry, 1989
- Effects of cholecystokinin and pentagastrin on rat hippocampal neurones maintained in vitroNeuropeptides, 1988
- Excitatory effects of cholecystokinin in rat hippocampus: pharmacological response compatible with ‘central’- or B-type CCK receptorsBrain Research, 1988
- Corticotropin Releasing Factor Decreases Postburst Hyperpolarizations and Excites Hippocampal NeuronsScience, 1983